|
On June 29, Houston’s Texas Medical Center and the Korea Health Industry Development Institute announced via news release their partnership that will expand TMC’s BioBridge, a global network designed to advance clinical research and commercialization through cooperation between foreign healthcare systems, clinicians and industry leaders.
The impact: As a result of this partnership, 12 Korean companies will establish on-site presences in Houston through the newly created TMC-KHIDI Residency Program, officials confirmed.
Zooming in: The pathway, titled TMC Republic of Korea BioBridge, grants Korean innovators greater opportunities to enter and expand their digital health, biotechnology and medical device companies within the U.S. healthcare market, officials said.
The Republic of Korea is the seventh country to be added to TMC’s BioBridge ecosystem and sits among the Netherlands, Australia, Ireland, Denmark, Japan and the United Kingdom, according to the center’s website.
|